Blue Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Blue Trust's PFE Position: Q3 2026 in Review
Blue Trust reduced its Pfizer (PFE) stake by 1% in Q3 2026, selling an estimated $30.9K and leaving 109,712 shares worth $3.13M. The position accounts for 0.03% of the portfolio, ranked #153.
Blue Trust first reported a position in PFE in Q2 2022 and has held it in 18 quarters since. The position peaked at $3.32M in Q4 2024. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Blue Trust held 109,712 shares of Pfizer worth $3.13M as of Q3 2026.
- Blue Trust sold 1,160 Pfizer shares in Q3 2026, an estimated $30.9K.
- Pfizer made up 0.03% of Blue Trust's portfolio in Q3 2026, its #153 holding.
- Blue Trust first reported a position in Pfizer in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Pfizer position peaked at $3.32M in Q4 2024.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.